Author
Listed:
- Clara Penas
(University of Miami Miller School of Medicine
Universitat Autònoma de Barcelona, CIBERNED)
- Marie E. Maloof
(University of Miami Miller School of Medicine)
- Vasileios Stathias
(University of Miami Miller School of Medicine)
- Jun Long
(University of Miami Miller School of Medicine)
- Sze Kiat Tan
(University of Miami Miller School of Medicine)
- Jose Mier
(University of Miami Miller School of Medicine)
- Yin Fang
(The Rockefeller University)
- Camilo Valdes
(Florida International University)
- Jezabel Rodriguez-Blanco
(University of Miami Miller School of Medicine)
- Cheng-Ming Chiang
(University of Texas Southwestern Medical Center)
- David J. Robbins
(University of Miami Miller School of Medicine)
- Daniel J. Liebl
(University of Miami Miller School of Medicine)
- Jae K. Lee
(University of Miami Miller School of Medicine)
- Mary E. Hatten
(The Rockefeller University)
- Jennifer Clarke
(University of Nebraska)
- Nagi G. Ayad
(University of Miami Miller School of Medicine)
Abstract
Cerebellar neuronal progenitors undergo a series of divisions before irreversibly exiting the cell cycle and differentiating into neurons. Dysfunction of this process underlies many neurological diseases including ataxia and the most common pediatric brain tumor, medulloblastoma. To better define the pathways controlling the most abundant neuronal cells in the mammalian cerebellum, cerebellar granule cell progenitors (GCPs), we performed RNA-sequencing of GCPs exiting the cell cycle. Time-series modeling of GCP cell cycle exit identified downregulation of activity of the epigenetic reader protein Brd4. Brd4 binding to the Gli1 locus is controlled by Casein Kinase 1δ (CK1 δ)-dependent phosphorylation during GCP proliferation, and decreases during GCP cell cycle exit. Importantly, conditional deletion of Brd4 in vivo in the developing cerebellum induces cerebellar morphological deficits and ataxia. These studies define an essential role for Brd4 in cerebellar granule cell neurogenesis and are critical for designing clinical trials utilizing Brd4 inhibitors in neurological indications.
Suggested Citation
Clara Penas & Marie E. Maloof & Vasileios Stathias & Jun Long & Sze Kiat Tan & Jose Mier & Yin Fang & Camilo Valdes & Jezabel Rodriguez-Blanco & Cheng-Ming Chiang & David J. Robbins & Daniel J. Liebl , 2019.
"Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesis,"
Nature Communications, Nature, vol. 10(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10799-5
DOI: 10.1038/s41467-019-10799-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10799-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.